Scancell

Scancell company information, Employees & Contact Information

Explore related pages

Related company profiles:

Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. We have developed a pipeline of ‘off-the-shelf’ vaccines which induce immune responses and highly tumour specific monoclonal antibodies that redirect immune cells or drugs. Our advanced therapeutic vaccine programmes, SCOPE and ModiFY, have shown promising efficacy in Phase 2 trials, demonstrating long-term survival in metastatic melanoma and a broad range of solid tumours.

Company Details

Employees
58
Address
Oxford, Gb
Phone
+44 20 7245 1100
Email
sc****@****ing.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Oxford
Looking for a particular Scancell employee's phone or email?

Scancell Questions

News

NHS signs deal with Scancell in ambitious skin cancer trial - Financial Times

NHS signs deal with Scancell in ambitious skin cancer trial Financial Times

Scancell taps into NHS matchmaking service for cancer trial - pharmaphorum

Scancell taps into NHS matchmaking service for cancer trial pharmaphorum

Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial - Pharmaceutical Technology

Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial Pharmaceutical Technology

Investor Update via Investor Meet Company. - Investegate

Investor Update via Investor Meet Company. Investegate

NHS to launch skin cancer vaccine test in new treatment drive - The Independent

NHS to launch skin cancer vaccine test in new treatment drive The Independent

Scancell: Broker raises price target after impressive cancer vaccine results - Proactive Investors

Scancell: Broker raises price target after impressive cancer vaccine results Proactive Investors

Melanoma patients in England get fast-track access to cancer vaccine - The Guardian

Melanoma patients in England get fast-track access to cancer vaccine The Guardian

SMALL CAP IDEA: Next 18 months are key for Scancell and its melanoma vaccine - This is Money

SMALL CAP IDEA: Next 18 months are key for Scancell and its melanoma vaccine This is Money

NHS programme to give melanoma patients fast-track access to skin cancer vaccine - PMLiVE

NHS programme to give melanoma patients fast-track access to skin cancer vaccine PMLiVE

NHS patients to take part in skin cancer vaccine drive - The Telegraph

NHS patients to take part in skin cancer vaccine drive The Telegraph

Scancell CEO on 2025 milestones and road ahead | AIM:SCLP, OTC:SCNLF - Proactive Investors

Scancell CEO on 2025 milestones and road ahead | AIM:SCLP, OTC:SCNLF Proactive Investors

Cancer vaccine trial to be expanded - Healthcare Leader

Cancer vaccine trial to be expanded Healthcare Leader

Skin cancer patients given fast-tracked access to ‘revolutionary’ cancer vaccine trial on NHS - Wired-Gov

Skin cancer patients given fast-tracked access to ‘revolutionary’ cancer vaccine trial on NHS Wired-Gov

Major skin cancer breakthrough after NHS announces 'exciting' new treatment - Metro.co.uk

Major skin cancer breakthrough after NHS announces 'exciting' new treatment Metro.co.uk

Scancell faces its big decision | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Scancell faces its big decision | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Scancell reports strong phase II results for melanoma immunotherapy - Proactive Investors

Scancell reports strong phase II results for melanoma immunotherapy Proactive Investors

Scancell Holdings: CEO L’Huillier Updates on SCOPE & Modi-1 Trials - ICYMI - Proactive Investors

Scancell Holdings: CEO L’Huillier Updates on SCOPE & Modi-1 Trials - ICYMI Proactive Investors

Scancell shares up 19% on melanoma trial fast-track news | AIM:SCLP, OTC:SCNLF - Proactive Investors

Scancell shares up 19% on melanoma trial fast-track news | AIM:SCLP, OTC:SCNLF Proactive Investors

Scancell: A rising star in oncology with upgraded prospects - Proactive Investors

Scancell: A rising star in oncology with upgraded prospects Proactive Investors

Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy - Frontiers

Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy Frontiers

Scancell gets South Africa’s approval for Covid-19 vaccines trial - Clinical Trials Arena

Scancell gets South Africa’s approval for Covid-19 vaccines trial Clinical Trials Arena

Scancell enjoys stock bounce on back of phase 2 snapshot for DNA cancer vaccine - Fierce Biotech

Scancell enjoys stock bounce on back of phase 2 snapshot for DNA cancer vaccine Fierce Biotech

Scancell eyes key cancer milestones and data - Proactive Investors

Scancell eyes key cancer milestones and data Proactive Investors

NHS to Fast-Track Patients to Melanoma Vaccine Trial - Medscape

NHS to Fast-Track Patients to Melanoma Vaccine Trial Medscape

NHS to fast-track skin cancer vaccine trials - Open Access Government

NHS to fast-track skin cancer vaccine trials Open Access Government

UK skin cancer patients fast-tracked into vaccine trial - Anadolu Ajansı

UK skin cancer patients fast-tracked into vaccine trial Anadolu Ajansı

Skin cancer patients could join Southampton vaccine project - BBC

Skin cancer patients could join Southampton vaccine project BBC

Genmab secures rights to second Scancell antibody in new million-dollar deal - medwatch.com

Genmab secures rights to second Scancell antibody in new million-dollar deal medwatch.com

Scancell names Dr Phil L'Huillier new CEO - Proactive Investors

Scancell names Dr Phil L'Huillier new CEO Proactive Investors

Is Scancell the best penny stock for me to buy today? - Fool UK

Is Scancell the best penny stock for me to buy today? Fool UK

Life-saving cancer vaccine soon available for thousands of NHS patients with deadly skin cancer - Daily Mail

Life-saving cancer vaccine soon available for thousands of NHS patients with deadly skin cancer Daily Mail

Skin cancer patients given fast-tracked access to ‘revolutionary’ cancer vaccine trial on NHS - Health Tech World

Skin cancer patients given fast-tracked access to ‘revolutionary’ cancer vaccine trial on NHS Health Tech World

Groundbreaking NHS skin cancer trials - National Health Executive

Groundbreaking NHS skin cancer trials National Health Executive

Scancell Holdings plc AGM Announcement and Role within FTSE AIM Index - Kalkine Media

Scancell Holdings plc AGM Announcement and Role within FTSE AIM Index Kalkine Media

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool - Wiley Online Library

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool Wiley Online Library

SMALL CAP IDEA: Next 18 months are key for Scancell and its melanoma vaccine - MSN

SMALL CAP IDEA: Next 18 months are key for Scancell and its melanoma vaccine MSN

Skin cancer patients will soon be able to test new NHS vaccine | ITV News - ITVX

Skin cancer patients will soon be able to test new NHS vaccine | ITV News ITVX

Scancell details further progress of lead immunotherapy assets - Vox Markets

Scancell details further progress of lead immunotherapy assets Vox Markets

Companies working on blockbuster health treatments: MIDAS SHARE TIPS - This is Money

Companies working on blockbuster health treatments: MIDAS SHARE TIPS This is Money

SMALL CAP MOVERS: Lupus drug patent lights up the market - This is Money

SMALL CAP MOVERS: Lupus drug patent lights up the market This is Money

British company secures the patent for revolutionary new cancer vaccine - The Independent

British company secures the patent for revolutionary new cancer vaccine The Independent

AIM’s best companies of 2025: shortlist revealed - Interactive Investor

AIM’s best companies of 2025: shortlist revealed Interactive Investor

‘So lucky’ – New Milton grandad in ground-breaking cancer vaccine trial - Advertiser and Times

‘So lucky’ – New Milton grandad in ground-breaking cancer vaccine trial Advertiser and Times

Scancell Holdings Plc (SCLP.L) Share Price, Updates & RNS News - Vox Markets

Scancell Holdings Plc (SCLP.L) Share Price, Updates & RNS News Vox Markets

'Exciting' needle-free skin cancer vaccine trial set to launch on NHS - Daily Express

'Exciting' needle-free skin cancer vaccine trial set to launch on NHS Daily Express

Top Scancell Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant